The scaling power of AI can simultaneously remove barriers to access, drive costs down system-wide and elevate the role of the human clinician so they can focus on human touch that their patients need.
Many health system technology executives have found that a strong digital transformation strategy requires sustained cross-department collaboration. At a recent conference panel, tech executives from UPMC and LifeBridge Health discussed why partnerships with the marketing department and analytics team are essential.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
To achieve diversity goals in research requires a multifaceted approach that makes clinical trial participation easier and uses analytics to help identify the right patients to recruit for a clinical trial.
Pharma companies already rely heavily on data and predictive analytics to assess new drugs. In the same way, analytics can be used to enhance legal advice and improve litigation strategies.
With analytics, faster, more informed decision-making is possible. This provides opportunities for healthcare leaders and organizations to find greater alignment on priorities, resources and outcomes.
Industry executives will share their insights at the INVEST Pop Health virtual conference, held in collaboration with New Orleans Business Alliance, scheduled for November 15-16. Register today.
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
A consortium of investors, led by Nordic Capital and Insight Partners, plan to acquire the company in a deal that would value it at $7.3 billion. It’s expected to close later this year or in early 2022.
Co-led by Kaiser Permanente, the Series D financing round will enable OM1 to expand its data networks into chronic disease areas, including rheumatology and behavioral health, and advance its AI analytics models.
The company will use the funds to develop new solutions and tools that can identify and correct anomalies in providers' revenue cycle processes and automate repetitive tasks.
Launched by 14 health systems in February, the data analytics company building a repository of de-identified data will use the funds to develop its platform that aims to support clinical decision making and drug development.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Realyze Intelligence, incubated at and funded by UPMC Enterprises, provides a platform that uses EMR data to identify chronic disease patients and help clinicians link them to appropriate treatment options. The platform leverages not only the structured data available in EMRs but also unstructured clinical notes.
Together, the companies will add race, ethnicity and language information as well as social determinants of health factors to a database of millions of Blues plan members. The insights gleaned will be used to design interventions and develop community partnerships to reduce disparities in care.
After a challenging 2020, health systems are looking to deploy strategies for recovery, especially to bolster financial health. One strategy health executives are considering is investing in predictive modeling technology that can help them manage patient demand and outcomes in the coming year.
In an unusual move, 14 major providers — including Trinity Health, CommonSpirit Health and Tenet — have come together to launch a data analytics company. Insights derived from the company's platform will be available to providers, biopharma companies and scientific researchers working to advance patient care.
The EHR giant is planning to buy Kantar Health, which provides data, analytics and research to the life sciences industry. Through the acquisition, Cerner aims to provide its clients with more access to data analytics and research expertise and engagement with life sciences companies.